Odell Beckham Jr. first noticed flakes throughout his iconic beard and hairline in his 20s; today, for the first time he is sharing his experience with ZORYVE® (roflumilast) topical foam, 0.3%, to ...

When Arcutis Biotherapeutics set out to build a community around seborrheic dermatitis, or seb derm, the first challenge was getting the members of that community to recognize that there was a disease ...

Seborrheic dermatitis is positively associated with a range of epithelial barrier diseases, including dermatologic, respiratory, gastrointestinal, and ocular diseases.

This article was reviewed by Knox Beasley, MD. Flakes on your scalp making you feel self-conscious? Let’s talk about seborrheic dermatitis vs dandruff. Whether your scalp feels like a snowglobe thanks ...

The NFL player and Super Bowl Champion Odell Beckham Jr. discusses his diagnosis of seborrheic dermatitis, or seb derm, with his personal dermatologist, as OBJ partners with Arcutis. The NFL Wide ...

Arcutis Biotherapeutics launched a campaign Monday focused on seborrheic dermatitis, highlighting personal journeys from patients with the disease as well as tips from dermatologists. The Clearing Up ...

The same condition that causes dandruff -- seborrheic dermatitis --also can cause a red and itchy beard. AndreyPopov Getty Images/iStockphoto If the skin under your facial hair is often red, irritated ...

Credit: Arcutis. Zoryve topical foam is a once-daily steroid-free formulation of a highly potent and selective phosphodiesterase type 4 inhibitor. The Food and Drug Administration (FDA) has approved ...

It’s been said before and it’s true: a healthy scalp is key to healthy hair. But for those dealing with pesky and sometimes painful scalp conditions like seborrheic dermatitis, that can be easier said ...

Seborrheic dermatitis is a chronic, inflammatory skin disease that affects more than 10 million people in the U.S. Survey found that, among adults with seborrheic dermatitis who use treatments, only ...

Please provide your email address to receive an email when new articles are posted on . On Dec. 16, 2023, roflumilast foam 0.3% was FDA-approved for the treatment of seborrheic dermatitis. The results ...